Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05429502 |
| Title | Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Novartis Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | child |
| Covered Countries | USA | ITA | GBR | DEU |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | United States | Details | |
| Cohen Children's Medical Center of New York | New Hyde Park | New York | 11040 | United States | Details | |
| St Jude s Childrens Research Hospital | Memphis | Tennessee | 38105-2794 | United States | Details | |
| Novartis Investigative Site | Cologne | 50937 | Germany | Details | ||
| Novartis Investigative Site | Milan | MI | 20133 | Italy | Details | |
| Novartis Investigative Site | Sutton | Surrey | SM2 5PT | United Kingdom | Details |